Efficacy and safety of prothrombin complex concentrate in patients treated with rivaroxaban or apixaban compared to warfarin presenting with major bleeding

Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage

(2018) Stefan T. Gerner et al.   ANNALS OF NEUROLOGY

International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

(2018) Robert Gosselin et al.   THROMBOSIS AND HAEMOSTASIS

Erratum to: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study

(2018) Sam Schulman et al.   THROMBOSIS AND HAEMOSTASIS

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

(2017) J. Douxfils et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

(2017) Charles V. Pollack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Heavy menstrual bleeding on Rivaroxaban - Comparison with Apixaban

(2016) Bethan Myers et al.   BRITISH JOURNAL OF HAEMATOLOGY

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

(2016) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sensitivity of routine coagulation assays to direct oral anticoagulants: patient samples versus commercial drug-specific calibrators

(2016) Ming Sheng Lim et al.   PATHOLOGY

Assessment of effectiveness of major bleeding management: proposed definitions for effective hemostasis: communication from the SSC of the ISTH

(2015) N. Khorsand et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Administration of 4-Factor Prothrombin Complex Concentrate as an Antidote for Intracranial Bleeding in Patients Taking Direct Factor Xa Inhibitors

(2015) Ramesh Grandhi et al.   World Neurosurgery

Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers

(2014) M. Levi et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays

(2014) A. Hillarp et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban

(2014) Graeme J. Hankey et al.   STROKE

Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding

(2013) Ravi Sarode et al.   CIRCULATION

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates

(2013) András Gruber et al.   THROMBOSIS AND HAEMOSTASIS

Guideline on the management of bleeding in patients on antithrombotic agents

(2012) Mike Makris et al.   BRITISH JOURNAL OF HAEMATOLOGY

Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran

(2012) Robert G. Hart et al.   STROKE

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban

(2012) Raphael Marlu et al.   THROMBOSIS AND HAEMOSTASIS

Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model

(2011) Anne Godier et al.   ANESTHESIOLOGY

Guidelines on oral anticoagulation with warfarin - fourth edition

(2011) David Keeling et al.   BRITISH JOURNAL OF HAEMATOLOGY

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

(2011) Elise S. Eerenberg et al.   CIRCULATION

Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists

(2011) Chiara Marchesi et al.   THROMBOSIS AND HAEMOSTASIS

Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy

(2011) Ammar Majeed et al.   THROMBOSIS RESEARCH

Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays

(2010) A. HILLARP et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS